🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Non-valvular Atrial Fibrillation (NVAF)

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. NCT04298723NA39 sites📍 Mannheim📍 Bad Neustadt an der Saale📍 Burgau Jena University Hospital · Tests: Percutaneous closure of the LAA (Watchman / Watchman FLX) Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion NCT06949319n/a1 site📍 Esbjerg Nedim Tojaga FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients NCT07385599NA1 site📍 Shatin Lifetech Scientific (Shenzhen) Co., Ltd. · Tests: LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease NCT05204212NA1 site📍 Lübeck Prof. Dr. med. Ingo Eitel · Tests: Left Atrial Appendage closure
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy